Combination of hypertension and diabetes causes rapid retinal cell death

Article

The combination of diabetes and hypertension-potentiated retinal oxidative and inflammatory stress accelerates retinal cell death and acellular capillary formation.

The combination of diabetes and hypertension-potentiated retinal oxidative and inflammatory stress accelerates retinal cell death and acellular capillary formation, reveals a paper in Molecular Vision.

A team led by Dr A.B. El-Remessy, Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia, Augusta, Georgia, USA, compared spontaneously hypertensive rats (SHR) to the outcomes of SHR with streptozotocin-induced diabetes (SHR+D). All rats were followed for 6 or 10 weeks, with Wistar rats were used as controls.

After six week both hypertension alone and hypertension with diabetes induced a quicker retinal cell death, compared to the control rats. The increase was linked to increased activation of phosphorylated-Jun N-terminal kinase (pJNK), phosphorylated-Akt inhibition, plasma and retinal lipid peroxides and soluble intracellular adhesion molecule-1 (sICAM-1) levels.

After 10 weeks there was a similar pattern in retinal nitrotyrosine, nuclear factor kappaB p65, and tumor necrosis factor-α expression being linked to exacerbated pJNK activation and acellular capillaries formation.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.